ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

ResMed Inc (ASX: RMD) shares are rising on Friday morning.

At the time of writing, the sleep disorder treatment company's shares are up 0.5% to $40.70.

This follows the release of the company's second quarter update before the market open.

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.

Image source: Getty Images

ResMed shares higher on Q2 update

For the three months ended 31 December, ResMed reported a 10% increase in revenue to US$1.3 billion. This was ahead of the US$1,265 million that Goldman Sachs was forecasting for the three months.

This reflects increased demand for the company's sleep devices and masks portfolio, as well as solid growth across its Residential Care Software business.

Revenue in the Americas, excluding Residential Care Software, grew by 12%. Whereas revenue in Europe, Asia, and other markets, excluding Residential Care Software, grew by 8% in constant currency. Finally, Residential Care Software revenue increased by 8% on a constant currency basis.

ResMed revealed that its gross margin increased by 300 basis points mainly due to manufacturing and logistics efficiencies and component cost improvements. Non-GAAP gross margin increased by 230 basis points due to the same factors.

This ultimately led to ResMed reporting a 52% increase in income from operation to US$417.2 million and a 29% jump in non-GAAP net income to US$358.3 million. The latter was ahead of Goldman's estimate of US$349 million.

Management commentary

ResMed chair and CEO Mick Farrell was pleased with the company's performance during the quarter. He said:

Our second quarter fiscal year 2025 top-line growth, margin expansion, and double-digit EPS growth were the result of increased demand for our sleep health and breathing health products and digital health solutions that people love, as well as our laser-focus on operational excellence.

We delivered 10% year-over-year revenue growth, 230 bps improvement in gross margin, and $309 million of operating cash flow. These results are a continuation of the incredible commitment from our team to create a clear market-leading value proposition in connected digital health.

Farrell also spoke positively about the company's future and believes that ResMed is well-placed for growth. This is being supported by smart watches now being able to diagnose sleep apnoea, which could drive increased awareness. He said:

Our ecosystem is unmatched and ResMed is well-positioned to capitalize on the once-in-a-generation opportunities we have with the recent introduction and adoption of consumer wearables that track sleep health, as well as use of GLP-1 therapies.

We believe these developments will drive increased patient flow as we continue to educate people on the benefits of healthy sleep and breathing, with care delivered right in their own home.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man leans forward propped on his elbows as he holds his clasped hands to his mouth in a worried pose as he gazes at his computer screen in a home setting.
Earnings Results

5 things reporting season taught ASX investors about FY27

Five FY26 lessons that shape the year ahead.

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Earnings Results

This broker is tipping 33% upside for Megaport shares

It could be time to buy the dip on Megaport shares.

Read more »

Elderly couple using laptop at home while drinking a cup of coffee.
Earnings Results

Why now is the time to buy MediBank Private shares: Expert

This stock comes with a strong yield and defensive profile.

Read more »

A gambler at a casino bets a pile of chips on one number.
Earnings Results

The Star Entertainment share price falls on FY26 earnings

The Star Entertainment Group posted a $307 million net loss for FY26, but cost cuts and stabilised revenues mark early…

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Financial Shares

Kina Securities lifts profit and dividend in half-year 2026 earnings

Kina Securities lifts 1H 2026 profit and dividend, buoyed by strong capital and digital initiatives.

Read more »

Businessman planning and analysing investment data.
Earnings Results

Kingsgate Consolidated posts record FY2026 earnings

NPAT jumps 843% and a dividend is declared on record gold and silver production.

Read more »

Woman at computer in office with a view
Earnings Results

Praemium posts FY26 revenue growth and completes platform integration

Praemium’s FY26 results show revenue growth, HNW momentum, and successful tech integration driving future opportunities.

Read more »

happy group of people
Earnings Results

Black Cat Syndicate posts record FY26 earnings and profit turnaround

Black Cat Syndicate reports record FY26 results, including a $374 million revenue surge and $86 million profit turnaround on strong…

Read more »